October 20th 2025
* Generic lenacapavir could be produced for $25 per person per year at scale, according to an analysis presented at IDWeek 2025 in Atlanta.
Making it easier to prevent ear infections in children
June 7th 2017Results of a new study show the feasibility and efficacy of preventing otitis media (OM), and potentially treat OM recurrence, through the simple use of a Band-Aid to deliver a vaccine targeted at one of the most common pathogens responsible for OM.
Gene variants relate to risk of respiratory infections and AOM
June 1st 2017Certain polymorphisms in mannose-binding lectin (MBL) and toll-like receptors (TLRs), genes that have a role in the innate immune system, promote susceptibility to or protection against respiratory and rhinovirus infections and acute otitis media (AOM), according to a study in Finnish infants.
CDC: Most children don’t get full benefit of flu vaccine
May 9th 2017Most children are not being adequately vaccinated against influenza, according to new data from the Centers for Disease Control and Prevention (CDC), which also just published a new report demonstrating the efficacy of the vaccine in reducing influenza-related deaths in children.
Live attenuated influenza vaccine “shelved” for poor efficacy
September 20th 2016Recent data has revealed the live attenuated influenza vaccine (LAIV), also known as the “nasal spray” vaccine, to be grossly ineffective, leading to the ACIP’s decision not to recommend its usage. As such, healthcare providers must be judicious in their choice of influenza vaccine with their patients.